[Pharmacological principles of diuretic therapy. 1].
D000086:Acetazolamide / Q000494:pharmacology; D000251:Adenosine Triphosphatases / Q000378:metabolism; D001692:Biological Transport; D004232:Diuretics / Q000494:pharmacology*; D004234:Diuretics, Osmotic / Q000494:pharmacology; D004976:Ethacrynic Acid / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000502:physiology; D000451:Mineralocorticoid Receptor Antagonists; D009941:Organomercury Compounds / Q000494:pharmacology; D009994:Osmolar Concentration; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D014882:Water-Electrolyte Balance; D014970:Xanthines / Q000494:pharmacology
D004232:Diuretics; D004234:Diuretics, Osmotic; D000451:Mineralocorticoid Receptor Antagonists; D009941:Organomercury Compounds; D014970:Xanthines; D005665:Furosemide; D012964:Sodium; D000251:Adenosine Triphosphatases; D004976:Ethacrynic Acid; D000086:Acetazolamide; D011188:Potassium
Pharmakologische Grundlagen der Diuretikatherapie. 1.